These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3812209)

  • 1. Regulation of low-density lipoprotein apolipoprotein B levels.
    Kesäniemi YA; Färkkilä M; Kervinen K; Koivisto P; Vuoristo M; Miettinen TA
    Am Heart J; 1987 Feb; 113(2 Pt 2):508-13. PubMed ID: 3812209
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic heterogeneity in very low-density lipoproteins.
    Shepherd J; Packard CJ
    Am Heart J; 1987 Feb; 113(2 Pt 2):503-8. PubMed ID: 3812208
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the LDL receptor in lipoprotein metabolism.
    Bilheimer DW; Grundy SM
    Adv Exp Med Biol; 1987; 210():123-30. PubMed ID: 3296682
    [No Abstract]   [Full Text] [Related]  

  • 4. Turnover of apoB in low density lipoprotein sub-fractions.
    Thompson GR; Teng B; Sniderman AD
    Agents Actions Suppl; 1984; 16():121-5. PubMed ID: 6592952
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of apolipoprotein E in modulating the metabolism of apolipoprotein B-48 and apolipoprotein B-100 containing lipoproteins in humans.
    Gregg RE; Brewer HB
    Adv Exp Med Biol; 1986; 201():289-98. PubMed ID: 3541520
    [No Abstract]   [Full Text] [Related]  

  • 6. Meaning of a modified LDL in humans.
    Avogaro P; Bittolo Bon G; Cazzolato G
    Adv Exp Med Biol; 1987; 210():209-12. PubMed ID: 3591550
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification of the low density lipoprotein receptor-binding site in apolipoprotein B100 and the modulation of its binding activity by the carboxyl terminus in familial defective apo-B100.
    Boren J; Lee I; Zhu W; Arnold K; Taylor S; Innerarity TL
    J Clin Invest; 1998 Mar; 101(5):1084-93. PubMed ID: 9486979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pravastatin increases the activity pf the LDL receptors in lymphocytes of individuals with heterozygous familial hypercholesterolemia].
    Alvarez-Sala LA; Mata P; Blázquez E; Garrido JA; Ordovás JM; Rubio MJ; de Oya M
    Rev Clin Esp; 1997 May; 197(5):317-22. PubMed ID: 9280964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Turnover and interconversion of LDL sub-fractions.
    Thompson GR; Kano M; Reeve J
    Adv Exp Med Biol; 1987; 210():105-9. PubMed ID: 3591541
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
    Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
    J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The formation of LDL: mechanisms and regulation.
    Havel RJ
    J Lipid Res; 1984 Dec; 25(13):1570-6. PubMed ID: 6397562
    [No Abstract]   [Full Text] [Related]  

  • 12. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why does plasma low density lipoprotein concentration in adults increase with age?
    Miller NE
    Lancet; 1984 Feb; 1(8371):263-7. PubMed ID: 6143004
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of primary hypercholesterolemia in humans.
    Vega GL; Grundy SM
    Am Heart J; 1987 Feb; 113(2 Pt 2):493-502. PubMed ID: 3544763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.
    Demant T; Bedford D; Packard CJ; Shepherd J
    J Clin Invest; 1991 Nov; 88(5):1490-501. PubMed ID: 1939641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of bezafibrate on serum lipid, lipoprotein and apoprotein levels in patients with hyperlipoproteinemia type II and IV].
    Bednarska-Makaruk M; Kuźmińska A; Chotkowska E; Kurjata P; Polakowska M; Broda G; Rywik S
    Pol Arch Med Wewn; 1992 Mar; 87(3):149-56. PubMed ID: 1523145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced cholesterol elimination and synthesis related to low-density lipoprotein metabolism.
    Miettinen TA; Kesäniemi YA; Färkkilä M; Koivisto P; Vuoristo M
    Am Heart J; 1987 Feb; 113(2 Pt 2):487-93. PubMed ID: 3812207
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
    Teng B; Sniderman AD; Soutar AK; Thompson GR
    J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accumulation of "small dense" low density lipoproteins (LDL) in a homozygous patients with familial defective apolipoprotein B-100 results from heterogenous interaction of LDL subfractions with the LDL receptor.
    März W; Baumstark MW; Scharnagl H; Ruzicka V; Buxbaum S; Herwig J; Pohl T; Russ A; Schaaf L; Berg A
    J Clin Invest; 1993 Dec; 92(6):2922-33. PubMed ID: 8254047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).
    Chappell DA
    J Clin Invest; 1989 Dec; 84(6):1906-15. PubMed ID: 2556448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.